Unknown

Dataset Information

0

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.


ABSTRACT: The transcription factor E2F1 is known to regulate cell proliferation and has been thought to modulate tumorigenesis via this mechanism alone. Here we show that mice deficient in E2F1 exhibit enhanced angiogenesis. The proangiogenic phenotype in E2F1 deficiency is the result of overproduction of vascular endothelial growth factor (VEGF) and is prevented by VEGF blockade. Under hypoxic conditions, E2F1 down-regulates the expression of VEGF promoter activity by associating with p53 and specifically down-regulating expression of VEGF but not other hypoxia-inducible genes, suggesting a promoter structure context-dependent regulation mechanism. We found that the minimum VEGF promoter mediating transcriptional repression by E2F1 features an E2F1- binding site with four Sp-1 sites in close proximity. These data disclose an unexpected function of endogenous E2F1: regulation of angiogenic activity via p53-dependent transcriptional control of VEGF expression.

SUBMITTER: Qin G 

PROVIDER: S-EPMC1544166 | biostudies-literature | 2006 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Qin Gangjian G   Kishore Raj R   Dolan Christine M CM   Silver Marcy M   Wecker Andrea A   Luedemann Corinne N CN   Thorne Tina T   Hanley Allison A   Curry Cynthia C   Heyd Lindsay L   Dinesh Deepika D   Kearney Marianne M   Martelli Fabio F   Murayama Toshinori T   Goukassian David A DA   Zhu Yan Y   Losordo Douglas W DW  

Proceedings of the National Academy of Sciences of the United States of America 20060711 29


The transcription factor E2F1 is known to regulate cell proliferation and has been thought to modulate tumorigenesis via this mechanism alone. Here we show that mice deficient in E2F1 exhibit enhanced angiogenesis. The proangiogenic phenotype in E2F1 deficiency is the result of overproduction of vascular endothelial growth factor (VEGF) and is prevented by VEGF blockade. Under hypoxic conditions, E2F1 down-regulates the expression of VEGF promoter activity by associating with p53 and specificall  ...[more]

Similar Datasets

| S-EPMC3344996 | biostudies-literature
2020-10-07 | GSE82106 | GEO
| S-EPMC3614511 | biostudies-literature
| S-EPMC3405207 | biostudies-literature
| S-EPMC4154238 | biostudies-literature
| S-EPMC3815650 | biostudies-literature
| S-EPMC4905305 | biostudies-other
| S-EPMC7921060 | biostudies-literature
| S-EPMC4563787 | biostudies-literature
| S-EPMC5830631 | biostudies-literature